SANUWAVE Health, Inc.
SNWV
$32.21
$0.8852.83%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 57.43% | 61.50% | 59.99% | 55.01% | 37.42% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 57.43% | 61.50% | 59.99% | 55.01% | 37.42% |
| Cost of Revenue | 23.53% | 33.05% | 33.95% | 57.09% | 47.10% |
| Gross Profit | 70.89% | 72.77% | 70.94% | 54.25% | 33.92% |
| SG&A Expenses | 44.36% | 31.14% | 30.21% | 2.40% | -12.20% |
| Depreciation & Amortization | 7.45% | 7.25% | 4.92% | 0.40% | -2.38% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 35.87% | 30.51% | 30.00% | 15.60% | 1.45% |
| Operating Income | 406.07% | 1,815.94% | 1,105.01% | 229.37% | 129.03% |
| Income Before Tax | -1,008.49% | -88.35% | -21.48% | 99.23% | 87.39% |
| Income Tax Expenses | 575.00% | 575.00% | 575.00% | 100.00% | 100.00% |
| Earnings from Continuing Operations | -1,007.98% | -88.47% | -21.56% | 99.22% | 87.37% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -1,007.98% | -88.47% | -21.56% | 99.22% | 87.37% |
| EBIT | 406.07% | 1,815.94% | 1,105.01% | 229.37% | 129.03% |
| EBITDA | 256.15% | 563.37% | 1,224.13% | 342.76% | 159.29% |
| EPS Basic | -162.60% | 34.23% | 56.78% | 100.80% | 81.64% |
| Normalized Basic EPS | -76.91% | 15.81% | 46.36% | 94.66% | 72.11% |
| EPS Diluted | -142.93% | 31.12% | 54.96% | 99.65% | 80.39% |
| Normalized Diluted EPS | -74.98% | 15.22% | 46.01% | 94.44% | 71.77% |
| Average Basic Shares Outstanding | 146.81% | 132.25% | 110.85% | 77.94% | 90.57% |
| Average Diluted Shares Outstanding | 140.70% | 137.70% | 117.31% | 85.77% | 99.53% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |